Download Print this page

Advertisement

Quick Links

413 432
Gram Negative Susceptibility Card
SUMMARY AND EXPLANATION
®
The VITEK
2 Gram Negative Susceptibility Card is
intended for use with the VITEK 2 Systems in clinical
laboratories as an in vitro test to determine the
susceptibility of clinically significant aerobic gram-
negative bacilli to antimicrobial agents when used as
instructed in the Product Information manual.
CONTENTS OF THE CARD
Antimicrobic
Amikacin
Ampicillin
Ampicillin/Sulbactam
Cefazolin
Cefepime
Cefoxitin
Ceftazidime
Ceftriaxone
Ciprofloxacin
c
Ertapenem
,
ESBL
Gentamicin
Levofloxacin
Meropenem
Nitrofurantoin
AST-GN75
Code
Concentration §
AN
8, 16, 64
AM
4, 8, 32
SAM
4/2, 16/8, 32/16
CZ
4, 16, 64
FEP
2, 8, 16, 32
FOX
8, 16, 32
CAZ
1, 2, 8, 32
CRO
1, 2, 8, 32
CIP
0.5, 2, 4
ETP
0.5, 1, 6
ESB
FEP 1, CTX 0.5, CAZ
0.5, FEP/CA 1/10,
CTX/CA 0.5/4, CAZ/CA
0.5/4
GM
4, 16, 32
LEV! 0.25, 0.5, 2, 8
MEM! 0.5, 2, 6, 12
FT
16, 32, 64
bioMérieux SA
INSTRUCTIONS FOR USE
A package insert is provided in the kit or downloadable
from www.biomerieux.com/techlib
See the Product Information manual for additional
Instructions for Use.
STORAGE CONDITIONS
Store at 2° to 8° C.
Calling Range
2
64
2
32
2/1
32/16
4
64
1
64
4
64
1
64
1
64
0.25
4
0.5
8
E. coli, K. pneumoniae, C. freundii,
C. koseri, E. aerogenes, E. cloacae,
Kox(-ESBL)**, M. morganii, P. mirabilis,
NEG
POS
E. coli, K. pneumoniae, K. oxytoca
1
16
0.12
8
E. cloacae, E. coli, K. pneumoniae,
S. marcescens, A. baumannii, A. lwoffii,
C. koseri, C. freundii, E. aerogenes,
E. sakazakii, K. oxytoca, M. morganii,
P. agglomerans, P. vulgaris, Pv. rettgeri,
Pv. stuartii, P. fluorescens, C. sakazakii
0.25
16
E. coli, K. pneumoniae, P. aeruginosa,
P. mirabilis, Acinetobacter spp.,
C. freundii, E. cloacae, K. oxytoca,
M. morganii, P. vulgaris, S. marcescens,
A. hydrophila, C. diversus, H. alvei,
P. multocida, Salmonella spp.,
16
512
English - 1
9310655-P1EN1 - 2015/08
FDA Indications for Use
CSAGNB**
CSAGNB**
CSAGNB**
CSAGNB**
CSAGNB**
CSAGNB**
CSAGNB**
CSAGNB**
CSAGNB**
P. vulgaris, S. marcescens
CSAGNB**
P. mirabilis, P. aeruginosa,
Shigella spp.
CSAGNB**

Advertisement

loading

Summary of Contents for Vitek AST-GN75

  • Page 1 The VITEK 2 Gram Negative Susceptibility Card is A package insert is provided in the kit or downloadable intended for use with the VITEK 2 Systems in clinical from www.biomerieux.com/techlib laboratories as an in vitro test to determine the susceptibility of clinically significant aerobic gram-...
  • Page 2 ",! etc. = See performance characteristics identified by the drug code with this symbol in the Comment column in Systems Product Information. **Eco(+ETEC) = E. coli (including susceptible enterotoxigenic strains implicated in traveler's diarrhea) QUALITY CONTROL ® CLSI Quality Control Organisms VITEK 2 Results Antimicrobic Code E. coli P. aeruginosa E. coli K.
  • Page 3 ® VITEK 2 AST-GN75 9310655-P1EN1 2015/08 LIMITATIONS Perform an alternative method of testing prior to reporting of results for the following antibiotic/organism combination(s): • Amikacin: Acinetobacter baumannii • Ampicillin: Citrobacter spp., Enterobacter spp., Pantoea spp., Serratia spp., Cronobacter sakazakii • Ampicillin/Sulbactam: Citrobacter spp., Enterobacter spp., Pantoea spp., Serratia spp., Cronobacter sakazakii...
  • Page 4 SUBJECT OF THE CLAIM. BIOMERIEUX, the blue logo, VITEK and bioLiaison are used, pending and/or registered trademarks belonging to bioMérieux SA or one of its subsidiaries, or one of its companies. The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.